Progress on S-1 in the treatment of advanced breast cancer
10.3969/j.issn.1006-0111.2015.06.021
- VernacularTitle:替吉奥治疗晚期乳腺癌的研究进展
- Author:
Ting ZHENG
1
;
Qijun QIAN
Author Information
1. 福建医科大学第一临床医学院
- Keywords:
S-1;
advanced breast cancer;
chemotherapy drug
- From:
Journal of Pharmaceutical Practice
2015;(6):557-560
- CountryChina
- Language:Chinese
-
Abstract:
S-1 is the third generation of fluorouracil derivative anti-cancer agent with small side effects ,efficacy ,and drug delivery is convenient .In a large number of clinical trials and continuous clinical application ,it showed the good effect for the treatment of advanced breast cancer ,which was expected to become the first-line chemotherapy drug for breast cancer treat-ment in the future .
